MIS Interbody Devices Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: MIPLIF Market, MITLIF Market, and 2 more

  • Year: 2025
  • Scope: 10 Years
  • Region: Global
  • Published Date: 04/01/2025
  • Type: MedCore

Product Description

The larges subsegment of this market in 2024 was the lateral lumbar interbody fusion (LLIF). It is expected that all subsegments keep growing in value with the MIPLIF being the fastest growing. On the other hand, MIPLIF has the smallest market value share because of a high decline in prices.

The full report suite on the global market for MIS interbody devices includes subsegments for the minimally invasive interbody devices such as minimally invasive posterior lumbar interbody fusion (MIPLIF), minimally invasive transforaminal lumbar interbody fusion (MITLIF), lateral lumbar interbody fusion (LLIF) and oblique lateral interbody (OLIF).

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET REPORT DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2024
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitor

GLOBAL MIS INTERBODY DEVICE MARKET TRENDS

Global MIS Interbody Device Market Growth, 2021 – 2031

  • MITLIF Market
  • LLIF Market
  • OLIF Market

RESEARCH SCOPE SUMMARY

Report Attribute Details
 Regions North America (Canada, United States)
Latin America
 (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
Western Europe
(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
Central & Eastern Europe
(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific
(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
Africa
(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
 Base Year  2024
 Forecast  2025-2031
 Historical Data  2021-2023
 Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
 Qualitative Coverage Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
 Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data,  iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

Table of Contents

MIS Interbody Device Market
4.1 Executive Summary
4.1.1 Global MIS Interbody Device Market Overview
4.1.2 Competitive Analysis
4.1.3 Procedure Segmentation
4.1.4 Market Segmentation
4.1.5 Regions Included
4.2 Introduction
4.2.1.1 Minimally Invasive Posterior Lumbar Interbody Fusion
4.2.1.2 Minimally Invasive Transforaminal Lumbar Interbody Fusion
4.2.1.3 Lateral Lumbar Interbody Fusion
4.2.1.4 Direct Lateral Interbody Fusion
4.2.1.5 eXtreme Lateral Interbody Fusion
4.2.1.6 Guided Lateral Interbody Fusion
4.2.1.7 Oblique Lateral Interbody Fusion
4.3 Procedure Numbers
4.3.1 MIPLIF Procedures
4.3.2 MITLIF Procedures
4.3.3 LLIF Procedures
4.3.4 OLIF Procedures
4.4 Market Overview
4.4.1 By Segment
4.4.2 By Region
4.5 Market Analysis and Forecast
4.5.1 Total MIS Interbody Device Market
4.5.2 MIPLIF Market
4.5.3 MITLIF Market
4.5.4 LLIF Market
4.5.5 OLIF Market
4.6 Drivers and Limiters
4.6.1 Market Drivers
4.6.2 Market Limiters
4.7 Competitive Market Share Analysis
 

Companies Included

·         Alevio Spine ·         Joimax
·         Alphatec Spine ·         KangLi Orthopaedics
·         Asap Endoscopic Products ·         Life Spine
·         Aurora Spine ·         Maxer Endoscopy
·         Blazejewski MEDI-TECH ·         Medacta International
·         BMK ·         Medyssey
·         Clariance ·         Mizuho Medical
·         CoreLink Surgical ·         Olympus
·         CTL Amedica ·         Orthofix
·         DePuy Synthes ·         Osteomed
·         Double Medical ·         Precision Spine
·         Drappon Medical ·         Pinnacle Spine Group
·         EMOS Technology ·         Precision Spine
·         Fujifilm ·         Richard Wolf
·         Globus Medical/NuVasive ·         Sanyou Medical
·         Integra LifeSciences ·         Schindler Endoskopie
·         SeaSpine ·         Tonglu Ba Medical
·         Shanghai Shiyin Photoelectric ·         TranS1
·         Shanghai Kinetic Spineart ·         U & I Corporation
·         SI-BONE ·         Ulrich Medical
·         SIGNUS Medical ·         VGI Medical
·         Spineart ·         Vimex Endoscopy
·         SpineFrontier ·         Weigao Ortho
·         Spineology ·         Xtant Medical
·         Stryker ·         ZimVie/Highridge Medical
·         Tian Song
 

Chart List

Chart 4‑1: MIS Interbody Device Market, Global, 2024 & 2031
Chart 4‑2: MIS Interbody Device Procedures, Global, 2024
Chart 4‑3: MIS Interbody Device Procedures by Segment, Global, 2021 – 2031
Chart 4‑4: MIS Interbody Device Market by Segment, Global, 2021 – 2031
Chart 4‑5: MIS Interbody Device Market by Region, Global, 2021 – 2031
Chart 4‑6: Leading Competitors, MIS Interbody Fusion Market, Global, 2024
 

Figure List

Figure 4‑1: MIS Interbody Device Procedure Segmentation
Figure 4‑2: MIS Interbody Device Market Segmentation
Figure 4‑3: MIS Interbody Device Regions Covered, Global (1 of 2)
Figure 4‑4: MIS Interbody Device Regions Covered (2 of 2)
Figure 4‑5: MIS Interbody Device Procedures by Segment, Global, 2021 – 2031
Figure 4‑6: MIS Interbody Device Procedures by Region, Global, 2021 – 2031
Figure 4‑7: MIS Interbody Device Procedures by Country, North America, 2021 – 2031
Figure 4‑8: MIS Interbody Device Procedures by Country, Latin America, 2021 – 2031
Figure 4‑9: MIS Interbody Device Procedures by Country, Western Europe, 2021 – 2031
Figure 4‑10: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 4‑11: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 4‑12: MIS Interbody Device Procedures by Country, Middle East, 2021 – 2031
Figure 4‑13: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 2)
Figure 4‑14: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 2)
Figure 4‑15: MIS Interbody Device Procedures by Country, Africa, 2021 – 2031
Figure 4‑16: MIPLIF Procedures by Region, Global, 2021 – 2031
Figure 4‑17: MIPLIF Procedures by Country, North America, 2021 – 2031
Figure 4‑18: MIPLIF Procedures by Country, Latin America, 2021 – 2031
Figure 4‑19: MIPLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 4‑20: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 4‑21: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 4‑22: MIPLIF Procedures by Country, Middle East, 2021 – 2031
Figure 4‑23: MIPLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 2)
Figure 4‑24: MIPLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 2)
Figure 4‑25: MIPLIF Procedures by Country, Africa, 2021 – 2031
Figure 4‑26: MITLIF Procedures by Region, Global, 2021 – 2031
Figure 4‑27: MITLIF Procedures by Country, North America, 2021 – 2031
Figure 4‑28: MITLIF Procedures by Country, Latin America, 2021 – 2031
Figure 4‑29: MITLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 4‑30: MITLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 4‑31: MITLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 4‑32: MITLIF Procedures by Country, Middle East, 2021 – 2031
Figure 4‑33: MITLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 2)
Figure 4‑34: MITLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 2)
Figure 4‑35: MITLIF Procedures by Country, Africa, 2021 – 2031
Figure 4‑36: LLIF Procedures by Region, Global, 2021 – 2031
Figure 4‑37: LLIF Procedures by Country, North America, 2021 – 2031
Figure 4‑38: LLIF Procedures by Country, Latin America, 2021 – 2031
Figure 4‑39: LLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 4‑40: LLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 4‑41: LLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 4‑42: LLIF Procedures by Country, Middle East, 2021 – 2031
Figure 4‑43: LLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 2)
Figure 4‑44: LLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 2)
Figure 4‑45: LLIF Procedures by Country, Africa, 2021 – 2031
Figure 4‑46: OLIF Procedures by Region, Global, 2021 – 2031
Figure 4‑47: OLIF Procedures by Country, North America, 2021 – 2031
Figure 4‑48: OLIF Procedures by Country, Latin America, 2021 – 2031
Figure 4‑49: OLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 4‑50: OLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 4‑51: OLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 4‑52: OLIF Procedures by Country, Middle East, 2021 – 2031
Figure 4‑53: OLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 2)
Figure 4‑54: OLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 2)
Figure 4‑55: OLIF Procedures by Country, Africa, 2021 – 2031
Figure 4‑56: MIS Interbody Device Market by Segment, Global, 2021 – 2031 (US$M)
Figure 4‑57: MIS Interbody Device Market by Region, Global, 2021 – 2031 (US$M)
Figure 4‑58: MIS Interbody Device Market, Global, 2021 – 2031
Figure 4‑59: Units Sold by Region, MIS Interbody Device Market, Global, 2021 – 2031
Figure 4‑60: Average Selling Price by Region, MIS Interbody Device Market, Global, 2021 – 2031 (US$)
Figure 4‑61: Market Value by Region, MIS Interbody Device Market, Global, 2021 – 2031 (US$M)
Figure 4‑62: MIPLIF Market, Global, 2021 – 2031
Figure 4‑63: Units Sold by Region, MIPLIF Market, Global, 2021 – 2031
Figure 4‑64: Average Selling Price by Region, MIPLIF Market, Global, 2021 – 2031 (US$)
Figure 4‑65: Market Value by Region, MIPLIF Market, Global, 2021 – 2031 (US$M)
Figure 4‑66: MITLIF Market, Global, 2021 – 2031
Figure 4‑67: Units Sold by Region, MITLIF Market, Global, 2021 – 2031
Figure 4‑68: Average Selling Price by Region, MITLIF Market, Global, 2021 – 2031 (US$)
Figure 4‑69: Market Value by Region, MITLIF Market, Global, 2021 – 2031 (US$M)
Figure 4‑70: LLIF Market, Global, 2021 – 2031
Figure 4‑71: Units Sold by Region, LLIF Market, Global, 2021 – 2031
Figure 4‑72: Average Selling Price by Region, LLIF Market, Global, 2021 – 2031 (US$)
Figure 4‑73: Market Value by Region, LLIF Market, Global, 2021 – 2031 (US$M)
Figure 4‑74: OLIF Market, Global, 2021 – 2031
Figure 4‑75: Units Sold by Region, OLIF Market, Global, 2021 – 2031
Figure 4‑76: Average Selling Price by Region, OLIF Market, Global, 2021 – 2031 (US$)
Figure 4‑77: Market Value by Region, OLIF Market, Global, 2021 – 2031 (US$M)
Figure 4‑78: Leading Competitors, MIS Interbody Fusion Market, Global, 2024
 

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

  • 2025
  • 10 Years
  • Global
  • 04/01/2025
  • MedCore
SKU: iDATA_GLMIS25_MC_IBD Categories: , , ,